Press Releases on January 5, 2023 - EIN Presswire - Press Release Distribution Service

Published on January 5, 2023 - 13:00 GMT

Galectin Therapeutics Announces the End of Enrollment of NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in ...

NORCROSS, Ga., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, announced today that in late December 2022, it ended enrollment of NAVIGATE, its seamless, adaptive, …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2023 - 13:00 GMT

APTIM Funds LSU College of the Coast & Environment Outreach for Middle and Highschool Students

Baton Rouge, La., Jan. 05, 2023 (GLOBE NEWSWIRE) -- APTIM, an industry leader in environmental and resiliency services, has formed a philanthropic partnership with the LSU College of the Coast & Environment (CC&E) to support local middle and high …

Distribution channels: Companies, Media, Advertising & PR ...

Published on January 5, 2023 - 13:00 GMT

Mobiquity Completes Financing to Help Fund the Launch of New Publisher Focused Platform for Monetization and Compliance

NEW YORK, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Mobiquity Technologies, Inc. (Nasdaq: MOBQ) (the “Company”), a leading provider of next-generation data intelligence and advertising technologies, is excited to announce the completion of a financing that will …

Distribution channels: Electronics Industry, Media, Advertising & PR ...

Published on January 5, 2023 - 13:00 GMT

Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference

WOBURN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery, access, safety and convenience, today …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2023 - 13:00 GMT

Paratek Pharmaceuticals Receives $36.4 Million Milestone Payment Associated with the Second Procurement of NUZYRA® (omadacycline) ...

Total Procurement-related Revenue Recognition of $38.1 Million to Paratek in December 2022 Procurement Triggered by Positive Top-Line Data from Pilot Efficacy Study of NUZYRA for the Treatment of Pulmonary Anthrax Announced in December BOSTON, Jan. 05, …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2023 - 13:00 GMT

Sunrun Closes $835 Million Non-Recourse Financings to Support Continued Growth

SAN FRANCISCO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN), the nation’s leading home solar, battery storage and energy services company, closed a $600 million non-recourse syndicated bank facility supporting a 335 MW portfolio of leases and …

Distribution channels: Banking, Finance & Investment Industry, Mining Industry ...

Published on January 5, 2023 - 13:00 GMT

Midland States Bancorp, Inc. to Announce Fourth Quarter 2022 Financial Results on Thursday, January 26

EFFINGHAM, Ill., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue its fourth quarter 2022 financial results after market close on Thursday, January 26, 2023. Midland States Bancorp will also …

Distribution channels: Banking, Finance & Investment Industry ...

Published on January 5, 2023 - 13:00 GMT

MBX Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

CARMEL, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing Precision Endocrine Peptide™ (PEP™) therapeutics to treat an array of endocrine disorders, today announced its participation at the …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on January 5, 2023 - 13:00 GMT

INVECTYS, INC. TO PARTICIPATE IN THE 41st JP MORGAN HEALTHCARE CONFERENCE ON JANUARY 9-12, 2023

Houston, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Invectys, Inc. “Invectys”, a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of cell therapy products for cancer patients, today announced …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2023 - 13:00 GMT

Hollywood Digest Announces Top Successful Entrepreneurs to Watch in 2023 that are Slaying the Game

Los Angeles, Jan. 05, 2023 (GLOBE NEWSWIRE) -- In 2023, keep an eye out for these top successful entrepreneurs that are spearheading the way in which we conduct business. The selected entrepreneurs are in the top of their field with new cutting edge ideas. …

Distribution channels:

Published on January 5, 2023 - 13:00 GMT

Cabaletta Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

PHILADELPHIA, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on January 5, 2023 - 13:00 GMT

Intercept Pharmaceuticals to Present at J.P. Morgan 41st Annual Healthcare Conference on January 12, 2023

MORRISTOWN, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today …

Distribution channels: Conferences & Trade Fairs, Culture, Society & Lifestyle ...

Published on January 5, 2023 - 13:00 GMT

PointMan Adopted by IAMGOLD to Improve Safety Operations

GRAND JUNCTION, Colo., Jan. 05, 2023 (GLOBE NEWSWIRE) -- ProStar Holdings Inc. ("ProStar®" or "the Company") (TSXV: MAPS) (OTCQX: MAPPF) (FSE: 5D00), a world leader in Precision Mapping Solutions®, is pleased to announce that …

Distribution channels: Business & Economy, Technology ...

Published on January 5, 2023 - 13:00 GMT

ShapeTX to Showcase Groundbreaking Advances in CNS in vivo RNA Editing, CNS-Targeting AAVs, and TruStable™ AAV Manufacturing at ...

SEATTLE, Jan. 05, 2023 (GLOBE NEWSWIRE) -- ShapeTX today announced Francois Vigneault, Ph.D., Co-founder and Chief Executive Officer, will present at the J.P. Morgan 41st Annual Healthcare Conference, on January 9, 2023 at 3:00 p.m. Pacific Time. The …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on January 5, 2023 - 13:00 GMT

Salarius Pharmaceuticals Announces Issuance of New U.S. Patent for Next-Generation Targeted Protein Degraders

Expands intellectual property portfolio with composition-of-matter patent protection for second novel molecular glue Protein degrader intellectual property portfolio now includes 16 issued patents across six unique patent families HOUSTON, Jan. 05, 2023 ( …

Distribution channels: Healthcare & Pharmaceuticals Industry, Law ...

Published on January 5, 2023 - 13:00 GMT

Atlas to Participate in the CJS Securities 23rd Annual New Ideas for the New Year Conference

AUSTIN, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Atlas Technical Consultants, Inc. (Nasdaq: ATCX) (“Atlas” or the “Company”), a leading Infrastructure and Environmental services provider, announced that L. Joe Boyer, Chief Executive Officer, and Jonathan …

Distribution channels: Business & Economy, Companies ...

Published on January 5, 2023 - 13:00 GMT

SAB Biotherapeutics Novel DiversitAb™ Platform Proven to Develop Anti-idiotype Antibodies to Help Treat Autoimmune Diseases

SIOUX FALLS, S.D., Jan. 05, 2023 (GLOBE NEWSWIRE) -- SAB Biotherapeutics (Nasdaq: SABS), a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2023 - 13:00 GMT

AltruBio to Present at Biotech Showcase™ 2023

SAN FRANCISCO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of immunological diseases with high unmet medical needs, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2023 - 13:00 GMT

Aligos Therapeutics on Track to Complete Phase 2-Enabling Activities in 2023 for its Clinically Validated THR-ß Drug Candidate for ...

– Final cohort of Phase 1 study projected to be complete in H1 2023 – – Phase 2-enabling GLP toxicology studies projected to be complete in H2 2023 – – Clinical update on all pipeline programs to be presented at the 2023 J.P. Morgan Healthcare Conference …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on January 5, 2023 - 13:00 GMT

iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine

BRYAN, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. …

Distribution channels: Law, Technology ...